These data suggest that the loss of intratumoral NF-κB is insufficient to inhibit global STAT3 activation in the tumor, nor is it able to enhance the reductions in tumor volume already mediated by STAT3 inhibition via AZD1480. Here, STAT3 is linked to neoplasm.